Trump taps a Fox News personality, a surgeon and a former Congressman to
lead public health agencies
Send a link to a friend
[November 23, 2024]
By MATTHEW PERRONE and AMANDA SEITZ
WASHINGTON (AP) — President-elect Donald Trump on Friday nominated Dr.
Marty Makary to lead the Food and Drug Administration, selecting a
surgeon and author who gained national attention for opposing vaccine
mandates and some other public health measures during the COVID-19
pandemic.
Makary, a professor at Johns Hopkins University, is the latest in a
string of Trump nominees who have declared the U.S. health system
“broken," vowing a shakeup. As part of a flurry of nominations late
Friday night, Trump also tapped doctor and former Republican Rep. Dave
Weldon of Florida to lead the Centers for Disease Control and
Prevention. Fox News contributor Janette Nesheiwat, meanwhile, is set to
be the nation's next surgeon general.
Some of Makary's views align closely with the man who is poised to be
his boss — prominent environmental lawyer and anti-vaccine organizer
Robert F. Kennedy Jr., whom Trump put forward as the next U.S.
Department of Health and Human Services secretary.
In books and articles, Makary has decried the overprescribing of drugs,
the use of pesticides on foods and the undue influence of pharmaceutical
and insurance companies over doctors and government regulators, points
that Kennedy has also harped on for years.
Trump said Makary, trained as a surgeon and cancer specialist, “will
restore FDA to the gold standard of scientific research, and cut the
bureaucratic red tape at the agency to make sure Americans get the
medical cures and treatments they deserve.”
Headquartered in the Maryland suburbs outside Washington, the 18,000
employees of the FDA are responsible for the safety and effectiveness of
prescription drugs, vaccines and medical devices as well as a swath of
other consumer goods, including food, cosmetics and vaping products.
Altogether those products represent an estimated 20% of U.S. consumer
spending annually, or $2.6 trillion.
Makary gained prominence on Fox News and other conservative outlets for
his contrarian views during the COVID-19 pandemic. He questioned the
need for masking and, though not opposed to the COVID-19 vaccine, had
concerns about booster vaccinations in young children. He was part of a
vocal group of physicians calling for greater emphasis on herd immunity
to stop the virus, or the idea that mass infections would quickly lead
to population-level protection.
The Centers for Disease Control and Prevention estimated that COVID-19
vaccinations prevented more than 686,000 U.S. deaths in 2020 and 2021
alone. While children faced much lower rates of hospitalization and
death from the virus, medical societies including the American Academy
of Pediatrics concluded that vaccinations significantly reduced severe
disease in the age group.
Makary has lamented how drugmakers used misleading data to urge doctors
to prescribe OxyContin and other opioids as low-risk, non-addictive pain
relievers. That marketing was permitted under FDA-approved labeling from
the 1990s, suggesting the drugs were safe for common ailments like back
pain.
In more recent years, the FDA has come under fire for approving drugs
for Alzheimer's, ALS and other conditions based on incomplete data that
failed to show meaningful benefits for patients.
[to top of second column]
|
Robert F. Kennedy Jr., speaks before Republican presidential nominee
former President Donald Trump at a campaign event Nov. 1, 2024, in
Milwaukee. (AP Photo/Morry Gash, File)
A push toward greater scrutiny of drug safety and effectiveness would be
a major reversal at FDA, which for decades has focused on speedier drug
approvals. That trend has been fueled by industry lobbying and fees paid
by drugmakers to help the FDA hire additional reviewers.
Kennedy has proposed ending those payments, which would require billions
in new funding from the federal budget.
Other administration priorities would likely run into similar
roadblocks. For instance, Kennedy wants to bar drugmakers from
advertising on TV, a multibillion-dollar market that supports many TV
and cable networks. The Supreme Court and other conservative judges
would likely overturn such a ban on First Amendment grounds that protect
commercial speech, experts note.
Less is known about Trump's pick for the Atlanta-based CDC, which
develops vaccines and monitors for infectious disease outbreaks.
Weldon is a staunch, self-described “pro-life” Republican. Legislation
he introduced more than 20 years ago outlawed human cloning. He also
brokered a deal with lawmakers to bar patents on human organisms,
including genetically engineered embryos. Weldon also advocated against
the removal of the feeding tube for Terri Schiavo, a Florida woman whose
family battle over her vegetative state turned into a national debate.
Weldon's nomination is likely to placate some anti-abortion advocates,
who have been concerned about Trump's nomination of Kennedy, a longtime
Democrat and proponent of abortion rights, as the nation's top health
official.
Weldon retired from his congressional seat in 2008, after 14 years in
public office. Earlier this year, he lost in a GOP primary for a seat in
the Florida Legislature.
If he's confirmed, he'll be in charge of more than 13,000 employees and
nearly 13,000 other contract workers.
Nesheiwat, meanwhile, will oversee 6,000 U.S. Public Health Service
Corps members if the Republican-controlled Senate approves her
nomination as the surgeon general. She is a medical director for an
urgent care company in New York. She appears regularly on Fox News and
has expressed frequent support for Trump, sharing photos of them
together on her social media pages.
Surgeons general also have the power to issue advisories, warning of
public health threats in the U.S. Those advisories can influence how the
government, public and medical community respond to health crises in the
country.
All contents © copyright 2024 Associated Press. All rights reserved
|